SEC Urges 2nd Circ. To Uphold Debarment For Takeda Exec

Law360, Los Angeles (January 24, 2013, 2:05 PM EST) -- The U.S. Securities and Exchange Commission on Tuesday urged the Second Circuit to affirm a district court's decision to bar a former Takeda Pharmaceuticals International Inc. executive and alleged insider trader from serving as an officer or director of a public company for 10 years, arguing that he would likely take advantage of any executive role.

Brent C. Bankosky, who allegedly used confidential information to make at least 13 illegal trades as an executive of Takeda Pharmaceuticals International Inc., agreed in February to pay $136,000 to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.